Today, we announce progress in our Fabry disease program, achieving important derisking milestones in our pathway to anticipated BLA submission. Learn more:

Where’s the partnership that you’ve been referencing for the past 10 months?

@sandymacrae23 @johnmarkels @Franca_ole Sangamo moved the goal post AGAIN - in Feb 6th PR you noted potential BLA submission 2nd 1/2 2025, now you note Q1 2026. 3-6 month delay means more dilution for current shareholders without a partnership or sale of Fabry asset near-term.

Lol what an achievement So proud of you guys 😂😂

Nobody cares. You’re going to the out of business since the bonehead CEO doesn’t know anything other than diluting shareholders and giving out false dates

Dillutuion again??

How do you spell bankruptcy? SANDYMACRAE! How this clown has been allowed to destroy this company and eviscerate its shareholders and employees is beyond me. Hands down the worst CEO of any biotech I have ever followed!